Mirae Asset Global ETFs Holdings’s Cabaletta Bio CABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$213K Buy
+68,592
New +$226K ﹤0.01% 2454
2025
Q2
– Sell
-26,622
Closed -$36.9K – 3040
2025
Q1
$36.9K Buy
26,622
+1,176
+5% +$2.51K ﹤0.01% 2897
2024
Q4
$57.8K Buy
25,446
+1,887
+8% +$6.63K ﹤0.01% 2873
2024
Q3
$111K Buy
23,559
+1,762
+8% +$10.2K ﹤0.01% 2671
2024
Q2
$162K Buy
+21,797
New +$267K ﹤0.01% 2361

Other funds holding CABA

Mirae Asset Global ETFs Holdings's CABA Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings opened a new position in Cabaletta Bio (CABA) in Q2 2026: 68,592 shares worth $213K. The stake represents ﹤0.01% of the portfolio and ranks #2454 among its holdings. This is a return to the name: Mirae Asset Global ETFs Holdings previously reported a position in CABA as recently as Q1 2025.

Mirae Asset Global ETFs Holdings first reported a position in CABA in Q2 2024 and has held it in 5 quarters since. 139 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 68,592 shares of Cabaletta Bio worth $213K as of Q2 2026.
  • Cabaletta Bio was a new Mirae Asset Global ETFs Holdings position in Q2 2026.
  • Cabaletta Bio made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2454 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Cabaletta Bio in Q2 2024 and has held it in 5 quarters since.
  • 139 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.